McKesson Corporation

OneMedNet Announces CEO Succession Plan

Retrieved on: 
Tuesday, April 2, 2024
Cloud, Growth, OMN, Health, Real, Patient, Hospital, Change Healthcare, IPO, McKesson Corporation, Retirement, Division, Management

MINNEAPOLIS, April 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), the leading curator of regulatory-grade imaging Real World Data (“iRWD™”), today announced that its President, Aaron Green, has assumed the role of President and Chief Executive Officer, in addition to an appointment to OneMedNet’s Board of Directors. Mr. Green will succeed CEO, Paul Casey, who has announced his retirement and who will continue to serve on the Board of Directors.

Key Points: 
  • Mr. Green will succeed CEO, Paul Casey, who has announced his retirement and who will continue to serve on the Board of Directors.
  • As President and CEO, Green will lead all facets of OneMedNet’s business involving its iRWD™ offering, including R&D, product, strategy, and sales across global markets.
  • It is my privilege to hand over the reins to Aaron.”
    “I am honored to be named, and eager to assume the CEO position here at OneMedNet,” commented Green.
  • “The CEO transition from Paul to Aaron is a direct reflection of the Board’s mindful succession planning and our confidence that the Company will see continued operational momentum as Aaron assumes the role of CEO,” added Dr. Jeffrey Yu.

Indegene Hosts Inaugural Strategic Advisory Board Meeting Chaired By Renowned Global Biopharma Leader Jill DeSimone

Retrieved on: 
Tuesday, April 2, 2024
Growth, Central Waqf Council, Strategic planning, Merck, Bristol Myers Squibb, McKesson Corporation, SAB, Health, Management

PRINCETON, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, hosted its first Strategic Advisory Board (SAB) meeting recently in New Jersey, chaired by Jill DeSimone, a well-known biopharma leader, with over four decades of global experience.

Key Points: 
  • PRINCETON, N.J., April 02, 2024 (GLOBE NEWSWIRE) -- Indegene, a digital-first, life sciences commercialization company, hosted its first Strategic Advisory Board (SAB) meeting recently in New Jersey, chaired by Jill DeSimone, a well-known biopharma leader, with over four decades of global experience.
  • She has previously worked with industry giants such as Bristol Myers Squibb, and Teva, and was the President of US Oncology at Merck.
  • Under Jill's leadership, the SAB aims to propel Indegene's market and customer growth by infusing outside expertise, perspective, and thought leadership.
  • "The Strategic Advisory Board will be pivotal to Indegene’s success, signifying our commitment to growth and innovation”, said Gaurav Kapoor, Executive Vice President, Indegene.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class Action Lawsuit

Retrieved on: 
Monday, April 1, 2024
Cendant, Mining, SSR, AIG, History, News, MCI Inc., McKesson Corporation, Fraud, Safety, SSRM, Miner, Cryptocurrency

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.

Key Points: 
  • Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
  • On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
  • Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
  • Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit

Retrieved on: 
Wednesday, March 27, 2024
Cendant, AIG, Patient, History, News, Rett, MCI Inc., McKesson Corporation, Rett syndrome, Complaint, Myenteric plexus, Fraud, Excellence

PHILADELPHIA, March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).

Key Points: 
  • PHILADELPHIA, March 27, 2024 (GLOBE NEWSWIRE) -- The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).
  • If you purchased Anavex stock during the Class Period and sustained a loss on your investment in these shares, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
  • You may contact the firm about this matter by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
  • The complaint alleges Anavex falsely portrayed to investors its research program and the likelihood that its Rett syndrome trials would be successful.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class Action Lawsuit

Retrieved on: 
Monday, March 25, 2024
Cendant, Mining, SSR, AIG, History, News, MCI Inc., McKesson Corporation, Fraud, Safety, SSRM, Miner, Cryptocurrency

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.

Key Points: 
  • Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
  • On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
  • Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
  • Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of SSR Mining Inc. Securities Class Action Lawsuit

Retrieved on: 
Wednesday, March 20, 2024
Cendant, Mining, SSR, AIG, History, News, MCI Inc., McKesson Corporation, Fraud, Safety, SSRM, Miner, Cryptocurrency

Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.

Key Points: 
  • Throughout the Class Period, the Company touted its focus on safety and compliance with applicable laws and regulations.
  • On February 13, 2024, a disastrous landslide at an SSR mine in Turkey buried nine miners.
  • Then, on February 18, 2024, SSR acknowledged that mining at the site would be suspended indefinitely after the mining permit for the site was revoked by the Turkish government.
  • Following this press release, the trading price of SSR fell approximately 5.9% to close at $4.62 per share on February 20, 2024.

Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment

Retrieved on: 
Tuesday, March 19, 2024
Principal, Spherion, Uterine fibroid, Organization, Growth, Health, Diabetes, Business administration, Patient, Xavier University, Medtronic, Engineering, Senior, McKesson Corporation, Woman, Marketing, Michigan State University, Minnesota State University Moorhead, Market access, Ethicon, Human resources, Management

The addition of these executive team members will support the company’s continued growth and adoption of the innovative Sonata Treatment.

Key Points: 
  • The addition of these executive team members will support the company’s continued growth and adoption of the innovative Sonata Treatment.
  • Commenting on these appointments, Skip Baldino, President and Chief Executive Officer of Gynesonics said, “I am very pleased to welcome Ted Stephens, Keith Chrzanowski, and Laurie Sandberg to Gynesonics.
  • Their collective contributions will help further accelerate adoption of the Sonata Treatment and help deliver on our commitment to provide women with a safe, effective alternative to more invasive treatment options for symptomatic fibroids.”
    Mr. Ted Stephens joins Gynesonics as its Chief Marketing and Strategy Officer.
  • Prior to joining Gynesonics he provided outstanding human resource and operational leadership to achieve success within several industries.

SHAREHOLDER ALERT: Barrack, Rodos & Bacine Notifies Shareholders of Anavex Life Sciences Securities Class Action Lawsuit

Retrieved on: 
Monday, March 18, 2024
Cendant, AIG, Patient, History, News, Rett, MCI Inc., McKesson Corporation, Rett syndrome, Complaint, Myenteric plexus, Fraud, Excellence

PHILADELPHIA, March 18, 2024 (GLOBE NEWSWIRE) --  The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).

Key Points: 
  • PHILADELPHIA, March 18, 2024 (GLOBE NEWSWIRE) --  The law firm of Barrack, Rodos & Bacine announces that a class action lawsuit has been filed on behalf of investors in Anavex Life Sciences Corp. (NASDAQ: AVXL) who purchased the stock between February 1, 2022 and January 1, 2024 (the “Class Period”).
  • If you purchased Anavex stock during the Class Period and sustained a loss on your investment in these shares, you are encouraged to contact us about your rights in this matter and the possibility of leading this class action lawsuit.
  • You may contact the firm about this matter by calling Linda Border or Mark Stein at 877-386-3304, or via email at [email protected] .
  • The complaint alleges Anavex falsely portrayed to investors its research program and the likelihood that its Rett syndrome trials would be successful.

McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities

Retrieved on: 
Tuesday, April 2, 2024
Professional Services, DEI (Diversity, Equity and Inclusion), Health, General Health, Pharmaceutical, Biotechnology, Oasis, McKesson Corporation, Pharmacy, Health equity, Pharmacy (shop), Health care

McKesson Corporation today announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.

Key Points: 
  • McKesson Corporation today announced the launch of Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
  • Led by McKesson's Global Impact Organization and Community Pharmacy & Health, Project Oasis seeks to identify and address pharmacy deserts, particularly in urban areas where residents face significant challenges in accessing essential pharmacy services.
  • After assessing numerous underserved communities across the nation, McKesson chose Avondale, OH, a neighborhood within Cincinnati, as the first activation site for Project Oasis.
  • With the support of Project Oasis, Manny and Altev Community Pharmacy are now proudly serving Avondale and its residents and helping to tackle healthcare disparities.

McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date

Retrieved on: 
Wednesday, March 27, 2024
Medical Supplies, Health, Hospitals, Physical Therapy, Managed Care, General Health, Pharmaceutical, MCK, McKesson Corporation

McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024.

Key Points: 
  • McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024.
  • The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
  • The live webcast will be available on McKesson’s Investor Relations website at http://investor.mckesson.com , along with the company’s earnings release, financial tables and slide presentation.